AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 2.360
+0.150 (6.79%)
Dec 10, 2025, 4:04 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 253.96 million as of December 10, 2025. Its market cap has increased by 186.20% in one year.
Market Cap
253.96M
Enterprise Value
197.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.36
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 253.96M, a decrease of -38.87%. That is a compound annual growth rate of -6.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 253.96M | 150.11% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | 342.16M | 120.98% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 111.60B |
| Getinge AB | 55.84B |
| Sectra AB | 53.25B |
| Camurus AB | 35.51B |
| Asker Healthcare Group AB | 33.90B |
| Medicover AB | 33.61B |
| BioArctic AB | 27.94B |
| AddLife AB | 21.40B |